Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  April    APR   FR0004037125

APRIL (APR)

SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
News SummaryMost relevantAll newsSector newsTweets 

APRIL : strengthens its international travel and expatriate insurance activity with the acquisition of MediCare International in the United Kingdom

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 03:52pm CEST

MediCare International is a wholesale broker specialising in health insurance for expatriates. The company 

currently generates  sales  of €2m with a portfolio of retail and corporate clients and has ten employees. 

MediCare International markets its policies both directly and through a network of 100 brokers in around 

fifteen countries, mainly in the United Kingdom and Switzerland.  MediCare International is a spin-off of a 

stand-alone business of brokerage firm LONMAR Global Risks, which had acquired it in 1993.

With this project, MediCare International will have an opportunity to take an important step forward with new 

growth prospects by joining a group with a firm standing in the health insurance field, both in France and 

abroad. This merger is perfectly in line with APRIL's international deployment strategy, aiming to build a 

leading global network revolving around travel and expatriate insurance and assistance. In this respect, the 

deal offers many advantages.

As a complement to APRIL Medibroker, the group will now have a UK & international management platform 

for  its clients and will be  in a position to tap more extensively MediCare International's access to Lloyd's 

offering of personal insurance solutions while strengthening its international network of specialised brokers 

to market its offers.

MediCare International will be consolidated in the group's accounts as from the second quarter of 2012.

APRIL (Compartment B, Deferred Settlement Service)

services to more than 6 million policyholders.

Sales for the first quarter of 2012 will be announced on Monday 30 April at market close.

Contact

Jean-Marc ATLAN

EKNO

Adviser to the CEO

+33 (0)6 07 37 20 44

[email protected]
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on APRIL
05/11 APRIL : ex-dividend day for annual dividend
05/04 APRIL : The APRIL group diversifies its business in Brazil with the acquisition ..
04/25 APRIL : reports sales of €227.7m, up 9.2% at end March 2017
03/08 APRIL : 2016 results Implementation of growth levers Stable current EBIT targete..
01/24 APRIL : delivers 2016 full-year sales of €861.2m, up 7.9%
2016 APRIL : APRIL starts reorganising its international operations
2016 APRIL : Emmanuel Morandini appointed as Group CEO
2016 APRIL : third-quarter 2016 sales
2016 APRIL : First half 2016 results
2016APRIL SA : half-yearly earnings release
More news
Sector news : Life & Health Insurance - NEC
06/22 ABERDEEN ASSET MANAGEMENT : UK competition watchdog clears Standard Life-Aberdee..
06/16 Supermarket stocks go stale on FTSE after tumultuous week
06/16 NOT YET AMAZON PRIME TIME : Australia retail sell-off overblown?
06/15DJMETLIFE : Promotes Two Senior Executives as Future CEO Succession Race Takes Sha..
06/15 Personal injury rate change to cost British motor insurers 3.5 billion pounds..
More sector news : Life & Health Insurance - NEC
Advertisement
Financials (€)
Sales 2017 880 M
EBIT 2017 -
Net income 2017 41,7 M
Debt 2017 -
Yield 2017 1,92%
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 0,63x
Capi. / Sales 2018 0,61x
Capitalization 554 M
More Financials
Chart APRIL
Duration : Period :
April Technical Analysis Chart | APR | FR0004037125 | 4-Traders
Full-screen chart
Technical analysis trends APRIL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 12,0 €
Spread / Average Target -11%
Consensus details
Managers
NameTitle
Emmanuel Morandini Chief Executive Officer
Bruno Rousset Chairman
Philippe Jean-Marie Marcel Independent Director
Bernard Belletante Director
André Arrago Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
APRIL13.01%629
AXA-0.27%65 811
PRUDENTIAL10.54%59 610
METLIFE-1.69%57 003
PRUDENTIAL FINANCIAL I..0.52%45 017
MANULIFE FINANCIAL COR..-2.19%35 631
More Results